Drug interactions don’t come to the top of my mind when I see GLP-1 agonists in use. We are fortunate that they do not have a lot of significant interactions, but I don’t think you should forget about them altogether. I’ve provided a list below of my...
LT is a 67-year-old white male presenting to your ambulatory care clinic for a CMR. He says his wife tells him he is taking too many medications and he wants your help evaluating his current regimen. Recent issues have been a rash due to dermatitis for which he was...
On May 13, 2022, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s Mounjaro (tirzepatide), a once-weekly injection for the treatment of type 2 diabetes mellitus (T2DM). Pathophysiology of Type 2 Diabetes Mellitus Incretins are the...
I recently blogged about my thoughts on the new diabetes guidelines. After that post, my friend Derek Borkowski who is the founder of Pyrls.com messaged me to offer followers of the Meded101 blog a free download. He’s put together a phenomenal resource with his...
The American Diabetes Association released their 2022 Diabetes Guidelines update. While I wouldn’t call the changes earth-shattering, there are some items in relation to pharmacotherapy that I feel are really important to note. The patient population that I work...
